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Abstract Apolipoprotein M (apoM) is a novel apolipoprotein
that is predominantly present in high-density lipoprotein.
Sensitive sequence searches, threading and comparative model
building experiments revealed apoM to be structurally related to
the lipocalin protein family. In a 3D model, characterized by an
eight-stranded anti-parallel L-barrel, a segment including Asn135
could adopt a closed or open conformation. Using site-directed
mutagenesis, we demonstrated Asn135 in wild-type apoM to be
glycosylated, suggesting that the segment is solvent exposed.
ApoM displays two strong acidic patches of potential functional
importance, one around the N-terminus and the other next to the
opening of the L-barrel. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Coronary artery disease (CAD) is one of the most common
diseases in industrialized countries. Lipoproteins and apolipo-
proteins can play signi¢cant roles in the pathogenesis of CAD
and structural information about these molecules will give us
a better understanding of their functional relationships in
both health and disease. The lipoproteins are a group of di-
verse particles consisting of a central core of cholesteryl esters
and triglycerides and an outer coat of phospholipids, choles-
terol and apolipoproteins. The apolipoproteins are responsible
for the structure, function and metabolism of the lipoproteins
[1,2].
The predominant apolipoprotein on the surface of high-
density lipoprotein (HDL) is apolipoprotein A-I (apoA-I),
which is an activator of lecithin-cholesterol acyltransferase
(LCAT) and promotes reverse cholesterol £ux. The other ma-
jor apolipoprotein (apoA-II) is a hepatic lipase activator. Oth-
er apolipoproteins found on HDL particles are apoA-IV,
apoC-I, apoC-II, apoC-III and apoD. Similar to apoA-I,
apoA-IV and apoC-I are LCAT activators. ApoC-II activates
lipoprotein lipase, whereas apoC-III is an inhibitor of the
same enzyme [1]. ApoD is a member of the lipocalin protein
family but its physiological role in HDL is still unknown [3].
Recently a new human HDL apolipoprotein of unknown
function, apoM, was discovered in our laboratory [4]. This
188 amino acid residues long protein was found to be mainly
associated with HDL, but could also be detected in triglycer-
ide-rich lipoproteins and low-density lipoprotein. The expres-
sion of apoM was found to be con¢ned predominantly to the
liver and kidney. Unlike other apolipoproteins, apoM has an
N-terminal signal peptide that cannot be processed by the
signal peptidase and the retained signal peptide is hypothe-
sized to anchor apoM to the single phospholipid layer of lipo-
proteins [4]. The apoM gene is highly conserved in several
mammalian species, which is consistent with an important
biological function.
Knowledge of the three-dimensional (3D) structure of a
protein is of major importance in providing insights into its
molecular functions, because proteins with similar folds may
have similar functions. Moreover, biochemical methods to
probe function without consideration of structural informa-
tion may lead to the wrong conclusion and are time-consum-
ing. Therefore, theoretical techniques allowing prediction of
3D structures followed by computer screening for potential
molecular functions used prior to experimental work are
very powerful research tools. At present, methods to predict
protein structures can be divided in two groups, ab initio and
comparative model building methods. While the complexity of
the conformational space has so far precluded ab initio pre-
diction of 3D structure of proteins, comparative (or homol-
ogy) modeling is a reliable approach [5,6].
We propose that apoM is structurally related to the lipoca-
lin protein family. This is based on sensitive sequence
searches, threading and comparative model building. The X-
ray structures of two lipocalins, mouse major urinary protein
(MUP) [7] and human retinol binding protein (RBP) [8], were
used as initial templates to build apoM. The conformation of
a segment including Asn135, near the opening of the lipocalin
binding pocket, was however di⁄cult to predict (e.g. open or
closed conformation). We used site-directed mutagenesis and
show that Asn135 is glycosylated. Thus, this segment was
built in an open conformation. We then analyze the structure
of apoM and propose potential molecular functions.
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2. Material and methods
2.1. Database search
The amino acid sequence of human apoM [4] (GenBank accession
number AF118393) was subjected to sequence search of public data-
bases using well established tools such as BLAST, WU-BLAST, PSI-
BLAST [9] and FASTA3 [10,11]. BLOCKS [12], FingerPRINTScan
(FPScan) [13] and Identify/eMotif [14] were used to search for se-
quence motifs. Because 3D structures are more conserved than amino
acids, we also used the fold recognition approach developed by Fisch-
er et al. [15].
2.2. Model construction
The atomic coordinates of mouse MUP (PDB entry 1mup) [7] and
RBP (PDB entry 1rbp) [8] were downloaded from Protein Data Bank
[16]. The sequence alignment of MUP, RBP and apoM was obtained
after manual adjustment of the sequence alignment output obtained
from the fold recognition experiment, multiple sequence alignments of
several lipocalins and structural alignment of MUP and RBP. The
MUP 3D structure was then used to predict apoM but for two regions
(see below). After analysis of the experimental templates, it was ob-
served that that the N-terminal segments of MUP and RBP are struc-
turally very di¡erent. The superposition of the two proteins is possible
only around residues Asn14 (in RBP) and Asn13 (in MUP). The
segment N-terminal to these Asn residues adopts a very di¡erent
conformation. In RBP, Cys4 is disul¢de bonded to Cys160, and the
N-terminal segment points in a very di¡erent direction as compared to
MUP. Because of the location of the Cys residues in the apoM se-
quence and previous experiments [4] suggesting that all apoM Cys are
involved in S^S bonds, it is very likely that a disul¢de bond involving
apoM Cys23^Cys167 mimics the RBP Cys4^Cys160 bridge (see Fig.
1). Therefore, we built the ¢rst residues of apoM following the overall
structure of RBP. The segment including apoM Asn135 was also
di⁄cult to build because this residue is part of a consensus sequence
for N-glycosylation. The corresponding residue in MUP is essentially
buried in the structure and because we show below that apoM Asn135
is glycosylated, the MUP structure could not be used to build this
region of apoM. The equivalent segment in RBP is essentially solvent
exposed and was thus used to build apoM (see Fig. 1). The predicted
transmembrane helix within the N-terminal region of apoM was not
built.
The apoM model was constructed with the Modeller package [17]
running on DEC Alpha workstations. This program uses spatial re-
straints from the X-ray templates as input and the model to build has
to satisfy as much as possible the set of restraints. Extra constraints
were also applied on secondary structure elements at the beginning of
the modeling process. Ten potential structures were generated and the
one with the fewest restraint violations was chosen for further geo-
metric optimization. Energy re¢nement was carried out with
CHARMM along with the all atoms CHARMM22 parameter set
[18,19]. Hydrogen atoms were added and partial charges assigned.
Backbone constraints were added at the beginning of the calculations
but were gradually decreased during the minimization. This structure
was then subjected to a simulated annealing protocol with all second-
ary structures ¢xed. The aim here was to allow the loop structures to
relax. Temperature was slowly tuned down from 500 K to 100 K (20
K every 10 ps after 20 ps equilibration) and at 100 K the simulation
was continued for another 50 ps. The ¢nal structure was then brie£y
energy minimized.
2.3. Electrostatic calculations
Electrostatic properties are important for macromolecular recogni-
tion and assembly [20,21]. Thus, we decided to compute some of the
electrostatic properties of apoM. Computations were carried out using
GRASP [22] or DelPhi [23,24]. The inner and outer dielectric con-
stants were set to 4 and 80, respectively and formal charges were
assigned to the main protein titratable groups (Arg, Lys, Asp and
Glu).
2.4. Site-directed mutagenesis
Two Asn residues, Asn135 and Asn148, could possibly be glycosy-
lated in apoM. To investigate which of these two were glycosylated,
two apoM mutants, Asn135Gln (N135Q) and Asn148Gln (N148Q),
were constructed using cloning vector pcDNA3 (Invitrogen) and
Quikchange Site-Directed Mutagenesis kit (Stratagene). Two comple-
mentary oligonucleotides for each mutant were employed. The
sequences of the sense oligonucleotides were: 5-GGTGGAATCAT-
GCTGCAGGAGACAGGCCAGGG (N135Q), 5-CGCTTTCTC-
CTCTACCAGCGCTCACCACATCCTCC (N148Q). The mutated
nucleotides are highlighted by underlined letters. The oligonucleotides
were from DNA Technologies A/S. Mutations were veri¢ed by DNA
sequencing using the BigDye Sequencing kit (Perkin Elmer).
2.5. In vitro expression
The mutants and the wild-type apoM were expressed in TNT Cou-
ple Reticulocyte Lysate Systems (Promega) with microsomes (canine
pancreatic microsomal membranes, Promega) according to the man-
ufacturer’s instructions. [35S]Methionine molecules (Amersham Phar-
macia) were incorporated during translation. The expressed products
(5 Wl) were treated with 5 Wl puri¢ed PNGase (0.25 Wg/Wl) at 20‡C
overnight. The PNGase-treated and untreated expression products
were analyzed by 12% reducing SDS^PAGE [25] and visualized using
a PhosphorImager (Molecular Dynamics).
3. Results and discussion
ApoM is a new apolipoprotein with unknown function. In
order to facilitate the elucidation of its physiological function,
we decided to predict and analyze its 3D structure. A fold
relationship to an already characterized protein often allows
information to be derived about a possible function of a pro-
tein. Protein functions can be divided into phenotypic, cellular
and molecular types depending on whether the known func-
tions are at the level of the whole organism, at the cellular, or
C
Fig. 1. A: Structural alignment. Structure-based sequence alignment of MUP, RBP and apoM. Because of the extreme sequence divergence in
the lipocalin family and some structural deviations, slight variations in the alignments are possible. The numbering follows the amino acid se-
quence for apoM and was taken from the PDB ¢les for MUP and RBP. The shadowed areas represent the conserved sequence motifs that
characterize the kernel lipocalins. Only motifs 1 and 2 are present in apoM. A star marks the experimentally identi¢ed glycosylated Asn (resi-
due 135). The MUP X-ray structure was used as template to build apoM but for the two underlined regions that come essentially from the
RBP structure. The lower case letters in the apoM sequence indicate regions that were not predicted (the present apoM model runs from resi-
dues 22 to 184). The hydrophobic N-terminal segment of apoM is not a cleavable signal peptide but rather a transmembrane K-helical signal
anchor. The proposed disul¢de (S^S) bonds for apoM are shown (dashed lines). A conserved contact in the lipocalins involves packing of an
Arg (apoM Arg149) against a Trp (apoM Trp47) together with hydrogen bonds between the guanido group of this Arg with main chain car-
bonyl groups of the N-terminal 310 helix (apoM His43 and Leu44). Secondary structure elements are taken from the MUP structure (hhhh
symbol de¢nes helices and bbbb de¢nes strands as part of the eight-stranded anti-parallel L-barrel surrounding the ligand binding site, labeled
A^H). The loops are labeled L1^L8. These segments are essentially conserved in apoM but for the K-helix between strands A and B, only
present in MUP. B: Ribbon drawing of apoM. Predicted secondary structure elements and loops are labeled as in A. Loops L1, L3, L5 and
L7 are located near the opening of the binding pocket. The other loops (L2, L4, L6 and L8) are on the opposite end. The regions where im-
portant structural changes are observed between MUP and RBP involve the N-terminal segment, the L1, L2, L3, L5 and L7 loops. The glyco-
sylated Asn135 residue is shown. The predicted S^S bonds are displayed in yellow. A conserved contact in the lipocalin family that corresponds
to apoM residues Arg149, Trp47, His43 and Leu44 is illustrated. A sphere highlights the lipocalin binding cavity. C: Ramachandran plot for
apoM. The plot was generated with Procheck. The Gly residues are shown as triangles. Residues are essentially located in the energetically al-
lowed regions.
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at the molecular level [26]. Several lines of evidence outlined
below suggest that apoM adopts the lipocalin fold, which will
form the basis for future experimental approaches aiming at
the investigation for apoM of known lipocalin functions. Fur-
thermore, the molecular surface of the apoM model was
screened in search of regions of potential functional impor-
tance such as putative binding sites.
The lipocalins form a family of proteins with very limited
amino acid sequence identity (often below 20%) but with a
common tertiary structure. In this family, an eight-stranded
anti-parallel L-barrel surrounds a central cavity generally lined
with hydrophobic/aromatic residues that enable binding of
small hydrophobic molecules [27^30]. Lipocalins ful¢ll a
wide variety of functions such as pheromone activity [7], en-
zymatic [31], cell regulation [32], and immune regulation [33].
They can be involved in the pathogenesis of diseases [34^37].
The lipocalin sca¡old has been used in biotechnology and
medicine [38]. The kernel group of lipocalin shares three con-
served sequence motifs which correspond to conserved struc-
tural elements, while a more diverse group (outlier lipocalins)
of the family shares no more than two of these motifs. The
disul¢de bonding pattern is not always conserved and for
instance RBP seems to be the only lipocalin containing three
S^S bridges [27]. Some lipocalins have a free cysteine respon-
sible for homo- and/or heterodimerization. Only three lipoca-
lins (apoD, Blc and lazarillo) are known to be attached to
biological membranes, either via a hydrophobic loop or via
a glycosylphosphatidylinositol anchor, and they all appear to
play a role in membrane biogenesis and repair [39].
3.1. Proposed lipocalin fold for ApoM
Database sequence searches (BLAST, WU-BLAST, PSI-
BLAST and FASTA3) were not able to match the apoM se-
quence with any protein family, while protein motif searches
(BLOCKS, FPScan and eMotif) suggested the amino acid
sequence of apoM to be related to the lipocalin family.
ApoM has two lipocalin sequence motifs and can be classi¢ed
into the more divergent group, the outlier lipocalins. The fold
recognition method indicated that the apoM sequence could
be accommodated unambiguously only into the lipocalin fold.
The most closely related experimental structure identi¢ed dur-
ing this search was MUP (PDB entry ¢le 1mup, z-score = 6.29)
followed by apoD (theoretical model PDB entry 2apd [40]).
Because the z-score is above the con¢dence threshold of the
method and since the protein motif searches suggested that
apoM adopts a lipocalin fold, we initially decided to predict
the 3D structure of apoM using the structural framework of
MUP.
3.2. Rationale of the modeling process and evaluation of the
apoM structure
The structure-based sequence alignment that was used to
build apoM is presented in Fig. 1A. Secondary structures
for the model were de¢ned according to Kabsch and Sanders
[41] (Fig. 1B). The stereochemistry of the apoM model was
evaluated with Procheck [42] (Fig. 1C). The root mean square
deviation for the CK trace between MUP and apoM is 1.37 Aî
(121 residues selected). Charged residues are essentially sol-
vent exposed or appropriately counterbalanced via formation
of salt bridges.
Earlier experimental results showed that apoM does not
form inter-molecular covalent bonds with other macromole-
cules [4], suggesting that all cysteines are involved in intra-
molecular disul¢de bonds. It was possible to build the apoM
Cys23^Cys167 disul¢de bond when the RBP structure was
used as initial template. The Cys95^Cys183 bond of apoM
is conserved in MUP (Cys68^Cys161) and RBP (Cys70^
Cys174). We assumed that apoM Cys128^Cys157 forms a
disul¢de bond because these two Cys are located close in
space in the 3D model. We thus suggest that apoM, like
RBP, has three disul¢de bridges. The overall apoM model
appeared reasonable at this stage with regard to the disul¢de
bridges but one key structural problem remained that in-
volved the region of Asn135. This residue is part of a con-
sensus sequence for N-glycosylation and is near the opening of
the hydrophobic binding pocket, which is characteristic of
lipocalins. When this segment of apoM was built using
MUP as structural template, Asn135 was essentially buried.
We concluded that this conformation is most likely incorrect,
because Asn135 is glycosylated and it is clear that a glycosy-
lated residue has to be essentially solvent exposed. There are
two potential glycosylation sites in apoM, one at Asn135 and
the second at Asn148, although the latter position has a pro-
line downstream of the Asn-Arg-Ser sequence and is therefore
likely not glycosylated. SDS^PAGE analysis of apoM, derived
either from in vitro translation experiments or from plasma,
demonstrated that there are two bands, one at 26 kDa repre-
senting the glycosylated protein and another less pronounced,
at approximately 23 kDa representing non-glycosylated apoM
[4]. Thus, it seems that a small quantity of non-glycosylated
apoM coexists with glycosylated apoM in vivo. In order to
determine the exact glycosylation site, wild-type apoM and
N135Q, N148Q mutants were expressed in vitro and the prod-
ucts were digested by PNGase. The absence of the glycosylat-
ed band at 26 kDa before and after the PNGase treatment in
the N135Q lane strongly supports that N135 in wild-type
apoM is glycosylated and that the N135Q mutation results
in the loss of the single glycosylation side chain in apoM
Fig. 2. Glycosylated Asn residue in apoM. To elucidate the exact
position of the glycosylation site in apoM, two mutants, N135Q
and N148Q, were constructed and expressed. The products were
then treated with PNGase overnight. Both treated (PNGase +) and
untreated (PNGase 3) products were analyzed by 12% reducing
SDS^PAGE.
FEBS 24965 12-6-01 Cyaan Magenta Geel Zwart
J. Duan et al./FEBS Letters 499 (2001) 127^132130
(Fig. 2). The segment including Arg121 of RBP, correspond-
ing to apoM Asn135, is solvent exposed and it was therefore
used to build this region of apoM.
3.3. Putative structure^function relationships of apoM
ApoM retains an uncleaved N-terminal signal peptide,
which most likely anchors the molecule into single layer lipids
on HDL. The major phospholipid in HDL is phosphatidyl-
choline, which has a positively charged choline group exposed
to the solvent [43]. Two electronegative regions are striking in
the apoM model and are located around the N-terminus and
the opening of the binding pocket (Fig. 3). Interaction be-
tween the N-terminal electronegative region of apoM and
the phosphatidylcholine of HDL is possible and could be of
functional importance. Moreover, strong negative potentials
were also found at the opening of the binding pocket and
could play a role for interactions with putative ligands or
membrane receptors. The opening of the binding pocket is
large in the model to accommodate the glycosylated
Asn135. The key residues lining the pocket are: Thr113,
Leu111, Tyr102, Met119, Leu82, Met73, Thr109, Val70,
Asn68, Phe49, Arg143, Tyr147, Leu145, and Met133. In ad-
dition, an exposed hydrophobic patch is present at the surface
of apoM and could be involved in intermolecular interactions.
4. Conclusion
ApoM is a new apolipoprotein of unknown function for
which we provide structural and functional information.
Based on threading, sequence searches and homology model-
ing, we propose that apoM adopts the lipocalin fold. There-
fore, the known functions of this family of protein can be
investigated for apoM. Three disul¢de bridges are suggested
to be present in apoM, which would make it a member of the
lipocalin subgroup of proteins with three S^S bonds. ApoM
has a glycosylated Asn residue at position 135. The amino
acids lining the cavity have been listed and are essentially
hydrophobic/aromatic. These residues can thus be mutated
to probe the putative ligand binding pocket of apoM. Electro-
negative regions are seen at the N-terminus of apoM and near
the entrance of the ligand binding pocket while a hydrophobic
patch is seen next to the L3 loop. These regions might be of
functional importance and can now be evaluated rationally
based on the 3D model structure.
Fig. 3. Outline of the molecular surface of apoM. Top: The solvent accessible surface of apoM is shown with the same orientation (left) as for
Fig. 1B and rotated (right) in order to see the other face of the protein. Side chains are colored as follows: blue (positively charged residues),
red (negatively charged), green (polar, and backbone atoms) and yellow (hydrophobic and aromatic). An exposed hydrophobic/aromatic patch,
involving the residues Pro65, Phe63, Cys95^Cys183, Ile88, Met90, Leu94 and Pro97, at the level of the L3 loop is indicated. Bottom: Surface
electrostatic potential of apoM. Negative potentials are in red and positive potentials in blue. Two acidic patches can be seen (see text).
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